Perbedaan Kertas Basuki Rachmat Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Kertas Basuki Rachmat Indonesia Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 434,4 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Kertas Basuki Rachmat Indonesia Tbk. jauh lebih besar — sekitar 2,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KBRI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 434,4 M | 166,01 M |
Volume | — | 324 rb |
Lot | — | 3,24 rb |
Perputaran | — | 77,68 jt |
Harga Rata-rata | — | 239,75 |
Nilai Transaksi | — | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.
Selengkapnya di halaman KBRI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →